On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

Medtronic (NYSE:MDT) said it has received European approval for its disposable continuous glucose monitor, the MidiMed 780G system with Simplera Sync sensor. The medical device maker said it was ...

Abbott has entered a global partnership focusing on the integration of its advanced FreeStyle Libre continuous glucose ...

Martin de Bock receives funding from Novo Nordisk, Medtronic, Ypsomed ... Pharmac’s decision to fund continuous glucose monitors and automated insulin delivery systems for the approximately ...

The Medtronic MiniMed™ 780G system consists of the following ... is intended for use with the MiniMed™ 780G system and the Guardian 4 transmitter to monitor glucose levels for the management of ...

For example, Medtronic's continuous glucose monitoring [CGM] systems have taken a backseat to DexCom (DXCM) and Abbott (ABT) due to poor user experience, innovation, and regulatory issues.

By analyzing data from Medtronic diabetes monitoring devices (insulin pumps and glucose monitors), IBM's artificial intelligence computer Watson can predict a low blood sugar problem up to three ...

Medtronic Plc is a medical technology company ... The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded ...

That person already used an insulin pump from Medtronic and is now using the glucose monitoring system from Medtronic as well. And after about one week, I find the results impressive. The ...

NeurAxis (NASDAQ:NRXS – Get Free Report) and Medtronic (NYSE:MDT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength ...

Medtronic's 780g insulin pump automates much ... blood glucose is a major advancement over the point-in-time blood glucose meters that typically provided two to four blood glucose readings in ...